亚甘油对缺血性中风患者28天死亡率的影响:使用MIMIC-IV数据库进行了回顾性队列研究
Huan Zuo1, Xin Zuo1, Linjing Wang2
1Department of Acupuncture, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in neurology
|September 29, 2025
概括
尼甘油 (NTG) 的使用,特别是在24小时内开始的静脉滴注并持续1-3天,与缺血性中风患者的28天死亡率降低有关. 这表明NTG在中风治疗中的特定治疗窗口.
科学领域:
- 心血管医学 心血管医学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 酸甘油 (NTG) 对缺血性中风患者的短期结果的影响尚未明确.
- 这项研究调查了NTG (路线,时间,持续时间) 和缺血性中风患者28天住院死亡率之间的关联.
研究的目的:
- 评估酸甘 (NTG) 对缺血性中风患者短期死亡率的影响.
- 根据患者的结果,确定NTG使用的最佳参数,包括路线,时间和持续时间.
主要方法:
- 一项回顾性队列研究包括3434名缺血性中风患者,其中356人接受NTG.
- 倾向性得分匹配 (1:1) 用于控制混因素.
- 考克斯的比例危险模型,卡普兰-梅尔分析和分层分析被用来评估NTG使用和死亡率之间的关联.
主要成果:
- 在使用NTG之前 (HR=0.52) 和在倾向分数匹配后 (HR=0.50),NTG使用与28天死亡率显著降低有关.
- 输入静脉滴注,在24小时内开始,持续时间为1-3天与较低的死亡率有显著的联系.
- 对于其他给药途径,延迟开始或更长的治疗持续时间,没有观察到显著的益处;剂量没有影响结果.
结论:
- 静脉注射甘,当在24小时内开始并服用1-3天时,与缺血性中风患者28天死亡率的降低有关.
- 这些发现突出了NTG在缺血性中风管理中的潜在治疗窗口.
- 需要进一步的前性研究来验证这些观察,并确认NTG的治疗疗效.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
4.3K
07:59Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
1.7K
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K
Angina V: Nursing Management
291
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
291
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Angina IV: Management
237
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
237
Acute Coronary Syndrome III: Diagnostic Studies
215
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
